| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/30/2011 | US20110159052 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 06/30/2011 | US20110159049 Pharmaceutical composition |
| 06/30/2011 | US20110159046 Controlled release formulations exhibiting an ascending rate of release |
| 06/30/2011 | US20110158991 Cytotoxic agents comprising new maytansinoids |
| 06/30/2011 | US20110158920 Method of producing a composition from an oleogel and an aqueous gel and the composition |
| 06/30/2011 | US20110158919 Aroma composition comprising o-coumaric acid to reduce or suppress undesirable taste impressions of sweeteners |
| 06/30/2011 | US20110158910 Microparticles comprising polymers with thioester bonds |
| 06/30/2011 | US20110158904 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 06/30/2011 | CA2785492A1 Lipids, lipid compositions, and methods of using them |
| 06/30/2011 | CA2785410A1 Tyrosine bioconjugation through aqueous ene-like reactions |
| 06/30/2011 | CA2785254A1 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue |
| 06/30/2011 | CA2785251A1 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
| 06/30/2011 | CA2785242A1 Carrier composition |
| 06/30/2011 | CA2785116A1 A combination for the treatment of osteoarthritis |
| 06/30/2011 | CA2785104A1 Topical ophthalmic peptide formulation |
| 06/30/2011 | CA2784849A1 Amphiphilic polymer functionalised by methionine |
| 06/30/2011 | CA2784705A1 Conjugate with target-finding ligand and use thereof |
| 06/30/2011 | CA2784645A1 Methods and compositions related to annexin 1-binding compounds |
| 06/30/2011 | CA2784179A1 Emulsion composition |
| 06/30/2011 | CA2782796A1 Compositions and methods for the treatment of angiogenesis-related eye diseases |
| 06/30/2011 | CA2780177A1 Abt-263 capsule |
| 06/29/2011 | EP2339003A2 APO-2 ligand substitutional variants |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338525A2 Remote detection of substance delivery to cells |
| 06/29/2011 | EP2338523A1 Polymer-factor VIII moiety conjugates |
| 06/29/2011 | EP2338522A1 Antitumoural therapies |
| 06/29/2011 | EP2338521A1 Lipopeptide- and lipoprotein-conjugates and its use |
| 06/29/2011 | EP2338520A1 Conjugate with targeting ligand and use of same |
| 06/29/2011 | EP2338519A1 Agent for treating myelofibrosis |
| 06/29/2011 | EP2338513A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/29/2011 | EP2338507A1 Method of treating malignancies through induction of blood immune responses |
| 06/29/2011 | EP2338505A2 Vault and vault-like carrier molecules |
| 06/29/2011 | EP2338504A2 Vault and vault-like carrier molecules |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | EP2338491A2 Pharmaceutical composition comprising a beta-carboline |
| 06/29/2011 | EP2338478A1 Method for producing liposomes |
| 06/29/2011 | EP2338476A1 Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non-esterified fatty acid |
| 06/29/2011 | EP2338475A2 Treating canker sores with patches to speed healing and relieve pain |
| 06/29/2011 | EP2337868A1 Detection of granulosa-cell tumors |
| 06/29/2011 | EP2337795A2 Mhc multimers in cancer vaccines and immune monitoring |
| 06/29/2011 | EP2337794A2 An improved process for pegylation of proteins |
| 06/29/2011 | EP2337586A2 Method of production of polyanionic drug-carrier conjugates |
| 06/29/2011 | EP2337585A1 Polymer conjugates of glp-2-like peptides |
| 06/29/2011 | EP2337584A2 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| 06/29/2011 | EP2337567A1 Veterinary preparation |
| 06/29/2011 | EP1379225B1 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
| 06/29/2011 | EP1181323B1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 06/29/2011 | EP1124567B2 Buffered compositions for dialysis |
| 06/29/2011 | EP1061915B1 Pharmaceutical formulations of taxanes |
| 06/29/2011 | CN1989963B Pharmaceutical compositions |
| 06/29/2011 | CN1942183B Isosorbide-containing jelly preparation |
| 06/29/2011 | CN1835769B KIM-1 antagonists and use to modulate immune system |
| 06/29/2011 | CN102112496A Hydrogel |
| 06/29/2011 | CN102112157A Conjugated proteins with prolonged in vivo efficacy |
| 06/29/2011 | CN102112156A Factor VIII polymer conjugates |
| 06/29/2011 | CN102112151A Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device |
| 06/29/2011 | CN102112138A Anti-tumor agent |
| 06/29/2011 | CN102112137A Film-forming liquid formulations for drug release to hair and scalp |
| 06/29/2011 | CN102112136A Composition for inhibiting expression of target gene |
| 06/29/2011 | CN102112117A Particle compositions with a pre-selected cell internalization mode |
| 06/29/2011 | CN102112116A 递送颗粒 Delivery particle |
| 06/29/2011 | CN102112112A Controlled release antimicrobial compositions and methods for treatment of otic disorders |
| 06/29/2011 | CN102112111A Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 06/29/2011 | CN102112108A Aqueous pharmaceutical formulation |
| 06/29/2011 | CN102112107A Controlled release copolymer formulation with improved release kinetics |
| 06/29/2011 | CN102108135A Aqueous cellulose acetate (CA) dispersion and preparation method thereof |
| 06/29/2011 | CN102108119A Multi-arm polyethylene glycol derivative, combination thereof with medicine, and gel |
| 06/29/2011 | CN102108102A Glycerol monooleate chitosan liquid crystal polymer |
| 06/29/2011 | CN102107010A Ondansetron hydrochloride medicament resin complex and application thereof |
| 06/29/2011 | CN102106993A Chinese medicinal composition for treating fatty liver and preparation method thereof |
| 06/29/2011 | CN102106941A Traditional Chinese medicine preparation for treating piles and preparation method of traditional Chinese medicine preparation |
| 06/29/2011 | CN102106925A Medlar polysaccharide and bifidobacterium snybiotic colonic targeting microecological regulator |
| 06/29/2011 | CN102106878A Preparation method of ginkgo leaf extract liquid-filling capsule |
| 06/29/2011 | CN102106874A New method for correcting flavor of traditional Chinese medicine granule |
| 06/29/2011 | CN102106846A Levogyration esmolol hydrochloride medicinal compositions and preparation method thereof |
| 06/29/2011 | CN102106844A Injection for treating zoonosis by formaldehyde |
| 06/29/2011 | CN102106843A Slow-release lung targeted microcapsule preparation of florfenicol and preparation method thereof |
| 06/29/2011 | CN102106841A Tamsulosin hydrochloride preparation and preparation method thereof |
| 06/29/2011 | CN102106840A Gemfibrozil capsule and preparation method thereof |
| 06/29/2011 | CN102106839A Alprazolam sustained-release preparation and preparation method thereof |
| 06/29/2011 | CN102106837A Glipizide sustained release tablets and preparation method thereof |
| 06/29/2011 | CN102106833A Pemetrexed disodium freeze-dried powder injection and preparation method thereof |
| 06/29/2011 | CN102106832A Ketoconazole nanometer suspension freeze-dried powder and preparation method thereof |
| 06/29/2011 | CN102106831A 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
| 06/29/2011 | CN102106830A Cefmetazole sodium liposome freeze-dried preparation and preparation method |
| 06/29/2011 | CN102106829A Sodium rabeprazole freeze-dried powder injection for injection, preparation method thereof and detection method thereof |
| 06/29/2011 | CN102106828A Thymalfasin sustained-release microsphere preparation and preparation method thereof |
| 06/29/2011 | CN102106826A Aripiprazole solid preparation and preparation method thereof |
| 06/29/2011 | CN102106825A Solid zopiclone preparation and preparation method thereof |
| 06/29/2011 | CN102106824A Eszopiclone solid preparation and preparation method thereof |
| 06/29/2011 | CN102106822A Fluconazole injection power and preparation method thereof |
| 06/29/2011 | CN102106821A Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments |
| 06/29/2011 | CN102106820A Epidermal growth factor nanolipid carrier preparation and preparation method thereof |
| 06/29/2011 | CN102106819A Preparation method and application of medicament-cyclodextrin inclusion compound self-emulsifying composition |
| 06/29/2011 | CN102106817A Pre-emulsified propylgallate concentrate and preparation thereof |
| 06/29/2011 | CN102106815A Florfenicol solution and preparation method thereof |
| 06/29/2011 | CN102106814A Novel high-efficiency anticoccidial medicament decoquinate solution and preparation method thereof |
| 06/29/2011 | CN102106813A Sodium new neohouttuyfonate injection and preparation method and application thereof |
| 06/29/2011 | CN102106812A Azithromycin ultrafine powder in-situ gel eye drops and preparation method thereof |